RESEARCH-USE BIOSIMILAR ANTIBODY

Narsoplimab

Monoclonal antibody · IgG4

MASP2IgG4RUO

Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2.

TARGETMASP2
YMonoclonal antibody
CATALOGSC-BS-356
CATALOG NUMBERSC-BS-356
MOLECULAR WEIGHTApprox. 143.1 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2.

Narsoplimab is a recombinant research-use antibody directed against MASP2.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Narsoplimab | StellaCyte